Feature image

What's New

Clozapine: Proposed changes to blood monitoring and prescribing requirements

Medsafe is seeking feedback on proposed changes to the blood monitoring and prescribing requirements for clozapine. There are separate consultations for consumers (people taking clozapine and their families) and for health professionals. Click on the link below to go to the consultations. The consultations close on 8 October 2025.

Current consultations

News and Events

Date Type Title
19/8/2025NoticesMedsafe performance statistics 2024/2025
13/8/2025ConsultationClozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for consumers and families - closes 8 October 2025
13/8/2025ConsultationClozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for healthcare professionals - closes 8 October 2025
31/7/2025CommitteesMedicines Classification Committee - Dates and Deadlines
31/7/2025Monitoring CommunicationUpdate - Anti-CD20 monoclonal antibodies (rituximab, ocrelizumab, obinutuzumab, ofatumumab) and the possible risk of pyoderma gangrenosum
24/7/2025NoticesGuidelines and Application Form for Approval to Prescribe Psychedelics
23/7/2025ConsultationTopical corticosteroids: Proposal for the package labelling to state their potency - Consultation now closes on 13 August 2025
22/7/2025Alert CommunicationWarning: advertisements claiming Medsafe approval or bearing the Medsafe logo are scams
16/7/2025CommitteesComments on agenda items for the 74th meeting of the Medicines Classification Committee
1/7/2025CommitteesAgenda for the 126th meeting of the Medicines Assessment Advisory Committee to be held on 18 July 2025
30/6/2025CommitteesMelatonin without a prescription